TAL2 (T-cell acute lymphoblastic leukemia 2)
2005-08-01 Katrina Vanura   AffiliationMedical University of Vienna, Dept. of Medicine I, Div. of Hematology, Waehringer Guertel 18-20, A - 1090 Vienna, Austria
DNA/RNA
Description
exons 1a, 2, 3, and 1b located 5-8 kb upstream of exon 4; coding region in exon 4 (326 bp)
Transcription
various mRNA isoforms were found in SUP-T3 and in the mouse, which also encompass upstream exons; gene products, however, always corresponded to the TAL2 protein encoded by exon 4
Proteins
Description
108 amino acids; basic Helix Loop Helix motif for protein dimerization and DNA-binding
Expression
in adult testes; in developing midbrain, dorsal diencephalon, rostroventral diencaphalic/telencephalic boundary, and anterior pons; pivotal role in the development of the mature central nervous system; not expressed during normal hematopoietic development
Function
transcription factor; TAL2 dimerizes with members of the class A subgroup of bHLH proteins (ie E47, E12, E2-2, HEB), as well as LIM-only proteins LMO1 and LMO2; heterodimers are formed intracellularly through stable interaction between bHLH domains of TAL2 and E47; TAL2/E47 heterodimers bind DNA in a sequence-specific manner that is dependent on the E-box element; TAL2/E12 heterodimers also have DNA-binding activity; TAL2 does not bind DNA in absence of E2A proteins; a significant fraction (60%) of TAL2 polypeptides from SUP-T3 exist in phosphorylated form, the rest is unphosphorylated; serine residue 100 of TAL2 is the potential site of phosphorylation by MAP kinases.
Implicated in
Entity name
Disease
T cell acute lymphoblastic leukemia found in < 1% of ALL, in 1-2% of T-ALL, rare but recurrent
Hybrid gene
Translocation of part of TCRB locus to a breakpoint 33 kb downstream of TAL2 mediated by the V(D)J recombinase via a fortuitous recombination signal sequence (YRSS) on chromosome 9; the translocation results in a signal joint fusion of TAL2 YRSS with the Db1 23-RSS; this gene product was detected in 6 of 10 thymus samples of healthy children with an estimated frequency of 1 in 10 million thymic cells; only upon secondary rearrangement of the TAL2/Db signal joint to the Jb2.6 segment, and deletion of the intervening sequence, the typical TAL2/Jb2.6 T-ALL junctions could be observed which presumably lead to overexpression of TAL2 and development of leukemia.
Fusion protein
TAL2 placed under control of TCRB enhancer leading to overexpression of TAL2 in T-cells and development of leukemia
Article Bibliography
| Pubmed ID | Last Year | Title | Authors |
|---|---|---|---|
| 8142619 | 1993 | TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia. | Baer R et al |
| 11071772 | 2000 | The T cell oncogene Tal2 is necessary for normal development of the mouse brain. | Bucher K et al |
| 12567187 | 2003 | Distinct t(7;9)(q34;q32) breakpoints in healthy individuals and individuals with T-ALL. | Marculescu R et al |
| 9931488 | 1999 | The leukemic oncogene tal-2 is expressed in the developing mouse brain. | Mori S et al |
| 2536065 | 1989 | Consistent breakage between consensus recombinase heptamers of chromosome 9 DNA in a recurrent chromosomal translocation of human T cell leukemia. | Tycko B et al |
| 1763056 | 1991 | TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia. | Xia Y et al |
| 8152805 | 1994 | Products of the TAL2 oncogene in leukemic T cells: bHLH phosphoproteins with DNA-binding activity. | Xia Y et al |
Other Information
Locus ID:
NCBI: 6887
MIM: 186855
HGNC: 11557
Ensembl: ENSG00000186051
Variants:
dbSNP: 6887
ClinVar: 6887
TCGA: ENSG00000186051
COSMIC: TAL2
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000186051 | ENST00000334077 | Q16559 |
Expression (GTEx)
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 24086757 | 2013 | The T-cell oncogene Tal2 Is a Target of PU.1 and upregulated during osteoclastogenesis. | 2 |
| 24086757 | 2013 | The T-cell oncogene Tal2 Is a Target of PU.1 and upregulated during osteoclastogenesis. | 2 |
| 21971700 | 2012 | Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer. | 29 |
| 21971700 | 2012 | Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer. | 29 |
| 12567187 | 2003 | Distinct t(7;9)(q34;q32) breakpoints in healthy individuals and individuals with T-ALL. | 6 |
| 12567187 | 2003 | Distinct t(7;9)(q34;q32) breakpoints in healthy individuals and individuals with T-ALL. | 6 |
Citation
Katrina Vanura
TAL2 (T-cell acute lymphoblastic leukemia 2)
Atlas Genet Cytogenet Oncol Haematol. 2005-08-01
Online version: http://atlasgeneticsoncology.org/gene/28/tal2
